Is Journey Medical Stock a Good Investment?
Journey Medical Investment Advice | DERM |
- Examine Journey Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Journey Medical's leadership team and their track record. Good management can help Journey Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Journey Medical's business and its evolving consumer preferences.
- Compare Journey Medical's performance and market position to its competitors. Analyze how Journey Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Journey Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Journey Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Journey Medical Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Journey Medical Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Journey Medical Stock
Researching Journey Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.92. Journey Medical Corp had not issued any dividends in recent years.
To determine if Journey Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Journey Medical's research are outlined below:
| Journey Medical Corp generated a negative expected return over the last 90 days | |
| Journey Medical Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 79.18 M. Net Loss for the year was (3.85 M) with profit before overhead, payroll, taxes, and interest of 33.11 M. | |
| Journey Medical Corp has a poor financial position based on the latest SEC disclosures | |
| About 30.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Journey Medical FDA Approval For Emrosi Makes This An Exciting Stock - Seeking Alpha |
Journey Medical Quarterly Cash And Short Term Investments |
|
Journey Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Journey Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Journey Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Journey Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Journey Medical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-06 | 2024-06-30 | -0.15 | -0.17 | -0.02 | 13 | ||
2024-11-13 | 2024-09-30 | -0.1475 | -0.12 | 0.0275 | 18 | ||
2024-03-21 | 2023-12-31 | -0.08 | -0.12 | -0.04 | 50 | ||
2023-08-08 | 2023-06-30 | -0.33 | -0.29 | 0.04 | 12 | ||
2018-08-06 | 2018-06-30 | -0.51 | -0.57 | -0.06 | 11 | ||
2015-05-12 | 2015-03-31 | -0.65 | -0.57 | 0.08 | 12 | ||
2017-05-08 | 2017-03-31 | -0.89 | -0.79 | 0.1 | 11 | ||
2023-05-22 | 2023-03-31 | -0.45 | -0.57 | -0.12 | 26 |
Know Journey Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Journey Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Journey Medical Corp backward and forwards among themselves. Journey Medical's institutional investor refers to the entity that pools money to purchase Journey Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Atria Investments Llc | 2024-09-30 | 44.4 K | Gladstone Institutional Advisory Llc | 2024-12-31 | 30 K | State Street Corp | 2024-09-30 | 25.6 K | Walleye Trading Advisors, Llc | 2024-09-30 | 23.1 K | Brighton Jones Llc | 2024-12-31 | 23 K | Perkins Capital Management Inc | 2024-09-30 | 22 K | Org Wealth Partners, Llc | 2024-12-31 | 20.9 K | Northern Trust Corp | 2024-09-30 | 17.7 K | Titleist Asset Management, Llc | 2024-09-30 | 14.2 K | Vanguard Group Inc | 2024-09-30 | 325.2 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 314.4 K |
Journey Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 95.05 M.Market Cap |
|
Journey Medical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | (0.05) | (0.06) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.22) | (0.21) |
Determining Journey Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Journey Medical is a good buy. For example, gross profit margin measures Journey Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Journey Medical's profitability and make more informed investment decisions.
Evaluate Journey Medical's management efficiency
Journey Medical Corp has return on total asset (ROA) of (0.1733) % which means that it has lost $0.1733 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2958) %, meaning that it created substantial loss on money invested by shareholders. Journey Medical's management efficiency ratios could be used to measure how well Journey Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 3rd of February 2025, Return On Tangible Assets is likely to drop to -0.06. In addition to that, Return On Capital Employed is likely to drop to -0.06. At this time, Journey Medical's Other Current Assets are very stable compared to the past year. As of the 3rd of February 2025, Intangible Assets is likely to grow to about 24.5 M, while Non Current Assets Total are likely to drop about 16.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.28 | 1.22 | |
| Enterprise Value Over EBITDA | 44.65 | 46.89 | |
| Price Book Value Ratio | 4.64 | 3.50 | |
| Enterprise Value Multiple | 44.65 | 46.89 | |
| Price Fair Value | 4.64 | 3.50 | |
| Enterprise Value | 109.6 M | 105.4 M |
The strategic initiatives led by Journey Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.924 |
Basic technical analysis of Journey Stock
As of the 3rd of February, Journey Medical retains the Standard Deviation of 4.17, risk adjusted performance of (0.05), and Market Risk Adjusted Performance of (1.44). Journey Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Journey Medical Corp market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if Journey Medical is priced fairly, providing market reflects its last-minute price of 4.55 per share. Given that Journey Medical Corp has information ratio of (0.08), we strongly advise you to confirm Journey Medical Corp's regular market performance to make sure the company can sustain itself at a future point.Journey Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Journey Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Journey Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Journey Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Journey Medical's Outstanding Corporate Bonds
Journey Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Journey Medical Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Journey bonds can be classified according to their maturity, which is the date when Journey Medical Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View |
Understand Journey Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Journey Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.44) | |||
| Mean Deviation | 3.1 | |||
| Coefficient Of Variation | (1,538) | |||
| Standard Deviation | 4.17 | |||
| Variance | 17.42 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (1.45) | |||
| Maximum Drawdown | 21.08 | |||
| Value At Risk | (4.80) | |||
| Potential Upside | 6.89 | |||
| Skewness | 0.4972 | |||
| Kurtosis | 2.48 |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (1.44) | |||
| Mean Deviation | 3.1 | |||
| Coefficient Of Variation | (1,538) | |||
| Standard Deviation | 4.17 | |||
| Variance | 17.42 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.62) | |||
| Treynor Ratio | (1.45) | |||
| Maximum Drawdown | 21.08 | |||
| Value At Risk | (4.80) | |||
| Potential Upside | 6.89 | |||
| Skewness | 0.4972 | |||
| Kurtosis | 2.48 |
Consider Journey Medical's intraday indicators
Journey Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Journey Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Journey Medical Corporate Filings
13A | 29th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 13th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 1st of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Journey Stock media impact
Far too much social signal, news, headlines, and media speculation about Journey Medical that are available to investors today. That information is available publicly through Journey media outlets and privately through word of mouth or via Journey internal channels. However, regardless of the origin, that massive amount of Journey data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Journey Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Journey Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Journey Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Journey Medical alpha.
Journey Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Journey Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Journey Medical Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Robyn Hunter | Treasurer Sec | Profile | |
| Ernest Galvan | VP Strategy | Profile | |
| Joseph Benesch | Interim Controller | Profile | |
| Claude Maraoui | President, Founder | Profile | |
| Robert Nevin | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Journey Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share | Quarterly Revenue Growth (0.58) | Return On Assets | Return On Equity |
The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Journey Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.